Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly plateaued but remained ahead of NVO stock as its drug pi …
Should You Sell Eli Lilly and Buy Novo Nordisk Stock After Q2?
view original post